# Revance Therapeutics Inc

Revance Therapeutics Inc is a security (CUSIP 761330109) tracked across SEC portfolio filings. 1 registered fund positions totaling $1.9M via N-PORT as of 2021-02-28.

## Summary

- Issuer: Revance Therapeutics Inc
- CUSIP: 761330109
- Asset category: EC
- 13F holders: 0
- N-PORT fund positions: 1
- N-PORT value: $1.9M
- N-PORT report: 2021-02-28

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [Small Cap Growth Fund](https://search.stillhousedata.com/fund/S000008021) | VALIC Co II | $1.9M | 64.40% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/761330109.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.